Global Orthobiologics Market Size, Share, and Trends Analysis Report
Market Size in USD Billion
CAGR :
% 
USD
9.37 Billion
USD
14.82 Billion
2024
2032
 予測期間 |
2025 –2032 |
 市場規模（基準年） |
USD 9.37 Billion |
 Market Size (Forecast Year) |
USD 14.82 Billion |
 CAGR |
% |
| Major Markets Players |
|
Global Orthobiologics Market Segmentation, By Product (Demineralized Bone Matrix (DBM), Allograft, Bone Morphogenetic Protein (BPM0), Viscosupplementation Products, Synthetic Bone Substitutes, and Others), Application (Osteoarthritis and DegenerativeArthritis, Spinal Fusion, Fracture Recovery, Soft Tissue Injuries, and Maxillofacial and Dental Applications), Type (Knee, Ankle, Hip, Wrist and Shoulder, Spine, and Others), and End-User (Hospitals and Ambulatory Centers, Research and Academic Institute, and Dental Clinics) - Industry Trends and Forecast to 2032
Orthobiologics Market Size
- The global orthobiologics market size was valued atUSD 9.37 billion in 2024and is expected to reachUSD 14.82 billion by 2032, at aCAGR of 5.90%during the forecast period
- This growth is driven by factors such as the increasing prevalence of musculoskeletal disorders, rising demand for minimally invasive surgical procedures, and advancements in stem cell and platelet-rich plasma therapies
Orthobiologics Market Analysis
- The global orthobiologics market is expanding as patients increasingly opt for minimally invasive procedures and regenerative therapies, driven by their safer and more effective outcomes compared to traditional surgical methods
- Innovations in stem cell therapy and platelet-rich plasma technologies are playing a pivotal role in this growth, offering faster recovery and improved healing, making them increasingly popular among both healthcare providers and patients
- North America is expected to dominate the orthobiologics market with 46.07% share due to strong healthcare system and high demand for orthopedic treatments
- Asia-Pacific is expected to be the fastest growing region in the Orthobiologics market during the forecast period with 7.09% share due to rising aging population and an increase in orthopedic surgeries
- The Viscosupplementation Products segment is expected to dominate the Orthobiologics market with the largest share of 40.5% in 2025 due to the increasing prevalence of osteoarthritis and the growing demand for non-surgical treatment options. Viscosupplementation, which involves the injection of hyaluronic acid into the joints, helps alleviate pain, improve mobility, and enhance the quality of life for patients suffering from joint degeneration
Report Scope and Orthobiologics Market Segmentation
|
Attributes |
Orthobiologics Key Market Insights |
|
Segments Covered |
|
|
Countries Covered |
North America
Europe
Asia-Pacific
Middle East and Africa
South America
|
|
Key Market Players |
|
|
Market Opportunities |
|
|
Value Added Data Infosets |
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework. |
Orthobiologics Market Trends
“Growing Popularity of Regenerative Medicine in Orthobiologics”
- The increasing adoption of regenerative medicine in orthobiologics is one of the most significant trends in the market today
- Regenerative treatments are gaining popularity due to their ability to promote natural healing by stimulating tissue repair and regeneration
- Stemcell therapies, platelet-rich plasma, and growth factor treatments are widely used to treat orthopedic injuries and conditions such as osteoarthritis, tendon injuries, and fractures
- The use of biologics to enhance healing processes is seen as a promising alternative to traditional surgical procedures, reducing recovery time and improving patient outcomes
- For instance, platelet-rich plasma therapy is being increasingly adopted in sports medicine to speed up recovery in athletes and prevent the need for invasive surgery
- In conclusion, the growing demand for non-invasive treatments and the advancements in tissue engineering are expected to drive the continued expansion of regenerative orthobiologics in the coming years
Orthobiologics Market Dynamics
Driver
“Rising Demand for Minimally Invasive Treatments”
- The demand for minimally invasive treatments is driving the growth of the orthobiologics market due to faster recovery and reduced complications
- Technologies like platelet-rich plasma and stem cell injections offer non-surgical solutions for tissue regeneration and healing
- Orthobiologic therapies are particularly effective in treating joint pain, fractures, and soft tissue injuries, gaining traction in both clinical and sports settings
- Patients are increasingly seeking these therapies due to their ability to expedite recovery time compared to traditional surgery
- For instance, professional athletes are opting for platelet-rich plasma injections to speed up recovery from injuries and return to their sport quickly
- In conclusion, s awareness and technology improve, the demand for orthobiologic treatments will continue to rise, supporting market growth
Opportunity
“Expanding Applications in Sports Medicine”
- Sports medicine offers a major opportunity for growth in the orthobiologics market, with increasing demand for faster recovery solutions
- Orthobiologic therapies like platelet-rich plasma and stem cell injections have proven effective in treating sports-related injuries such as tendonitis, ligament tears, and cartilage damage
- These therapies promote natural healing, reduce re-injury risk, and allow athletes to return to their sport quickly
- For instance, professional athletes and sports teams have successfully used orthobiologic therapies to speed up recovery and improve performance
- Growing clinical trials and research support the efficacy of these treatments, leading to increased demand in the sports medicine sector
- In conclusion, as acceptance continues to rise, the orthobiologics market is expected to expand with more innovation and growth opportunities in this field
Restraint/Challenge
“High Treatment Costs and Limited Insurance Coverage”
- A major challenge in the orthobiologics market is the high cost of treatment, making it less accessible to a wide range of patients
- Therapies like stem cell therapy and platelet-rich plasma require advanced equipment, skilled practitioners, and specialized procedures, all contributing to the high costs
- Many insurance providers do not cover these treatments, categorizing them as experimental or elective, which limits access for patients
- For instance, patients who cannot afford out-of-pocket expenses may be reluctant to choose these therapies, slowing market growth
- The high costs and limited coverage are also a barrier in regions with less-developed healthcare systems, hindering wider adoption of orthobiologic treatments
- In conclusion, better insurance coverage and affordability are achieved, the growth of the orthobiologics market will face financial constraints
Orthobiologics Market Scope
The market is segmented on the basis of product, application, type, and end user.
|
Segmentation |
Sub-Segmentation |
|
By Product |
|
|
By Application |
|
|
By Type |
|
|
By End User |
|
In 2025, the viscosupplementation products segment is projected to dominate the market with a largest share in product segment
The viscosupplementation products segment is expected to dominate the orthobiologics market with the largest share of 40.5% in 2025 due to the increasing prevalence of osteoarthritis and the growing demand for non-surgical treatment options. Viscosupplementation, which involves the injection of hyaluronic acid into the joints, helps alleviate pain, improve mobility, and enhance the quality of life for patients suffering from joint degeneration. As a minimally invasive procedure, it is preferred by both patients and healthcare providers for its ability to delay or avoid the need for more invasive surgeries.
The spinal fusion segment is expected to account for the largest share during the forecast period in technology segment
In 2025, the spinal fusion segment is expected to dominate the market with the largest market share of 50.05% due to the increasing prevalence of spinal disorders, such as degenerative disc disease and spinal arthritis. Spinal fusion procedures, which involve the use of biologics to promote the healing of spinal bones, are widely adopted to treat conditions that cause chronic back pain or instability. The rising aging population, along with an increase in lifestyle-related conditions, is driving the demand for these procedures. Additionally, advancements in spinal fusion technologies, including the use of orthobiologics for faster recovery and enhanced outcomes, are contributing to the segment's growth.
Orthobiologics Market Regional Analysis
“North America Holds the Largest Share in the Orthobiologics Market”
- North America is the leading region in the global orthobiologics market, with 46.07% share due to strong healthcare system and high demand for orthopedic treatments
- The U.S. is the largest market due to its advanced healthcare infrastructure and high prevalence of musculoskeletal conditions
- Significant investment in research and development by both international and domestic companies has introduced advanced therapies to the region
- Reimbursement policies that support the use of orthobiologics in medical procedures encourage widespread adoption across various healthcare settings
- The region’s focus on innovation, along with major research universities, continues to drive the growth of new orthobiologic treatments
“Asia-Pacific is Projected to Register the Highest CAGR in the Orthobiologics Market”
- The Asia Pacific region is experiencing rapid growth in the orthobiologics market due to rising aging population and an increase in orthopedic surgeries
- Countries such as China and India are leading this growth, with a growing awareness of the benefits of orthobiologic treatments
- The region is benefitting from improvements in medical infrastructure and healthcare access, which is facilitating broader adoption of these therapies
- Rising healthcare expenditures and government initiatives are enhancing the availability of advanced treatments and technologies
- Local manufacturers are expanding their presence and developing products to meet both domestic and international market demands
Orthobiologics Market Share
The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.
The Major Market Leaders Operating in the Market Are:
- XTANT MEDICAL (U.S.)
- Arthrex, Inc. (U.S.)
- SeaSpine (U.S.)
- NuVasive, Inc. (U.S.)
- Bioventus (U.S.)
- Kuros Biosciences (Switzerland)
- K2M, Inc. (U.S.)
- RTI Surgical Holdings, Inc. (U.S.)
- Orthofix Holdings, Inc. (U.S.)
- Globus Medical Inc (U.S.)
- Harvest Technologies (U.S.)
- Zimmer Biomet (U.S.)
- Stryker (U.S.)
- Medtronic (Ireland)
- DePuy Synthes (U.S.)
- Sanofi (France)
- SEIKAGAKU CORPORATION (Japan)
- Locate Bio Ltd. (U.K.)
- MTF Biologics (U.S.)
- Alphatec Spine, Inc. (U.S.)
- Exactech, Inc. (U.S.)
Latest Developments in Global Orthobiologics Market
- In March 2023, the orthobiologics market concluded on a positive note despite challenges like staffing shortages, supply chain constraints, and inflation. Anticipated growth in 2023 is expected to be driven by the resurgence of elective procedures and strategic initiatives by key industry players. Key focus areas include reshaping the competitive landscape, advancements in osteobiologics, and shifts in the U.S. bone replacement and sports medicine markets
- In September 2024, Temple OrthoBiologics launched with a mission to revolutionize sports medicine by preventing scar tissue formation—a long-standing challenge in orthopedic recovery. Their flagship product, TX-33, is an intra-articular treatment combining advanced biomaterials and targeted drug delivery, aimed at enhancing tissue repair post-injury or surgery
- In August 2023, the American Academy of Orthopaedic Surgeons (AAOS) highlighted the potential of orthobiologics—treatments utilizing biological substances like platelet-rich plasma—to offer less invasive options for musculoskeletal conditions such as osteoarthritis and tendinopathies. These therapies aim to alleviate pain, reduce inflammation, and enhance healing, potentially delaying or avoiding the need for surgery
- In February 2023, projections indicated that the global orthobiologics market, valued at approximately USD 6.5 billion in 2022, is expected to reach USD 10.3 billion by 2030, growing at a CAGR of 5.9%. This growth is driven by increased product launches, rising prevalence of orthopedic conditions, and advancements in biologic materials. Bone allografts are anticipated to maintain a leading market share due to their effectiveness in procedures like spinal fusion. North America is projected to remain the dominant regional market, supported by a strong presence of key industry players and favorable reimbursement policies
SKU-
世界初のマーケットインテリジェンスクラウドに関するレポートにオンラインでアクセスする
- インタラクティブなデータ分析ダッシュボード
- 成長の可能性が高い機会のための企業分析ダッシュボード
- カスタマイズとクエリのためのリサーチアナリストアクセス
- インタラクティブなダッシュボードによる競合分析
- 最新ニュース、更新情報、トレンド分析
- 包括的な競合追跡のためのベンチマーク分析のパワーを活用
調査方法
データ収集と基準年分析は、大規模なサンプル サイズのデータ収集モジュールを使用して行われます。この段階では、さまざまなソースと戦略を通じて市場情報または関連データを取得します。過去に取得したすべてのデータを事前に調査および計画することも含まれます。また、さまざまな情報ソース間で見られる情報の不一致の調査も含まれます。市場データは、市場統計モデルと一貫性モデルを使用して分析および推定されます。また、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。詳細については、アナリストへの電話をリクエストするか、お問い合わせをドロップダウンしてください。
DBMR 調査チームが使用する主要な調査方法は、データ マイニング、データ変数が市場に与える影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、特許分析、価格分析、企業市場シェア分析、測定基準、グローバルと地域、ベンダー シェア分析が含まれます。調査方法について詳しくは、お問い合わせフォームから当社の業界専門家にご相談ください。
カスタマイズ可能
Data Bridge Market Research は、高度な形成的調査のリーダーです。当社は、既存および新規のお客様に、お客様の目標に合致し、それに適したデータと分析を提供することに誇りを持っています。レポートは、対象ブランドの価格動向分析、追加国の市場理解 (国のリストをお問い合わせください)、臨床試験結果データ、文献レビュー、リファービッシュ市場および製品ベース分析を含めるようにカスタマイズできます。対象競合他社の市場分析は、技術ベースの分析から市場ポートフォリオ戦略まで分析できます。必要な競合他社のデータを、必要な形式とデータ スタイルでいくつでも追加できます。当社のアナリスト チームは、粗い生の Excel ファイル ピボット テーブル (ファクト ブック) でデータを提供したり、レポートで利用可能なデータ セットからプレゼンテーションを作成するお手伝いをしたりすることもできます。
